Guy Lalonde
Impact in
- Endocrinology top 5%
- Vibrio bacteria research studies
- Escherichia coli research studies
- Microbiology top 5%
- Microbial infections and disease research
Papers in
-
- Microbial infections and disease research 5
- Co-authors
- P O’HanleyJocelyn DupuisJean L. RouleauR. LallierGeun Eog JiG. OlivierK. R. MittalDavid Leblanc
- Journals
- Canadian Journal of Microbiology (2 papers)American Heart Journal (2 papers)Molecular Microbiology (1 paper)Stem Cells (1 paper)Food and Chemical Toxicology (1 paper)
- Partner nations
- CanadaUnited StatesGreece
In The Last Decade
Guy Lalonde
23 papers receiving 589 citations
Peers
Comparison fields: 5 of 94
- Endocrinology 134
- Microbiology 83
- Cardiology and Cardiovascular Medicine 189
- Immunology 161
- Molecular Medicine 34
Countries citing papers authored by Guy Lalonde
This map shows the geographic impact of Guy Lalonde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guy Lalonde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guy Lalonde more than expected).
Fields of papers citing papers by Guy Lalonde
This network shows the impact of papers produced by Guy Lalonde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guy Lalonde. The network helps show where Guy Lalonde may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Guy Lalonde, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2023 | 4 | |
| 3 | 2023 | 0 | |
| 4 | 2022 | 5 | |
| 5 | 2019 | 6 | |
| 6 | 2001 | 3 | |
| 7 | Oral anticoagulant therapy for heart disease: results in actual cardiology practice. | 2000 | 7 |
| 8 | 1999 | 20 | |
| 9 | 1994 | 11 | |
| 10 | 1990 | 28 | |
| 11 | 1990 | 168 | |
| 12 | Captopril does not prevent nitroglycerin tolerance in heart failure. | 1990 | 18 |
| 13 | 1989 | 16 | |
| 14 | 1989 | 7 | |
| 15 | 1989 | 46 | |
| 16 | 1987 | 7 | |
| 17 | 1986 | 1 | |
| 18 | 1986 | 4 | |
| 19 | 1980 | 108 | |
| 20 | 1974 | 17 |
About Guy Lalonde
Guy Lalonde is a scholar working on Microbiology, Cardiology and Cardiovascular Medicine, Health, Toxicology and Mutagenesis, Molecular Medicine and Cancer Research, having authored 25 papers that have together received 631 indexed citations. Recurring topics across this work include Microbial infections and disease research (5 papers), Bacteriophages and microbial interactions (4 papers), Carcinogens and Genotoxicity Assessment (3 papers), Smoking Behavior and Cessation (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Glycosylation and Glycoproteins Research (2 papers), Air Quality and Health Impacts (2 papers) and Indoor Air Quality and Microbial Exposure (2 papers). The work is most often cited by research in Endocrinology (134 citations), Microbiology (83 citations), Cardiology and Cardiovascular Medicine (189 citations), Immunology (161 citations) and Molecular Medicine (34 citations). Guy Lalonde has collaborated with scholars based in Canada, United States and Greece. Frequent co-authors include P O’Hanley, Jocelyn Dupuis, Jean L. Rouleau, R. Lallier, Geun Eog Ji, G. Olivier, K. R. Mittal, David Leblanc, Paul Gardner and Thomas V. McDonald. Their work appears in journals such as Canadian Journal of Microbiology, American Heart Journal, Molecular Microbiology, Stem Cells and Food and Chemical Toxicology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.